Clinical outcomes of carbapenem-resistant gram-negative bacterial bloodstream infection in patients with end-stage renal disease in intensive care units: a multicenter retrospective observational study
Infection · 2025
DOI: 10.1007/s15010-024-02343-5 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Infection, 2025. Verfasst von Yu-Chao Lin und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan. Hauptthemen laut MEDLINE: Carbapenems, Anti-Bacterial Agents, Kidney Failure, Chronic, Gram-Negative Bacterial Infections. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 38 Literaturangaben.
Themen: Intensivpflege
Abstract (Originalsprache)
BACKGROUND: Carbapenem-resistant gram-negative bacteria (CRGNB) present a considerable global threat due to their challenging treatment and increased mortality rates, with bloodstream infection (BSI) having the highest mortality rate. Patients with end-stage renal disease (ESRD) undergoing renal replacement therapy (RRT) face an increased risk of BSI. Limited data are available regarding the prognosis and treatment outcomes of CRGNB-BSI in patients with ESRD in intensive care units (ICUs). METHODS: This multi-center retrospective observational study included a total of 149 ICU patients with ESRD and CRGNB-BSI in Taiwan from January 2015 to December 2019. Clinical and microbiological outcomes were assessed, and multivariable regression analysis was used to evaluate the independent risk factors for day-28 mortality and the impact of antimicrobial therapy regimen on treatment outcomes. RESULTS: Among the 149 patients, a total of 127 patients (85.2%) acquired BSI in the ICU, with catheter-related infections (47.7%) and pneumonia (32.2%) being the most common etiologies. Acinetobacter baumannii (49.0%) and Klebsiella pneumoniae (31.5%) were the most frequently isolated pathogens. The day-28 mortality rate from BSI onset was 52.3%, and in-hospital mortality was 73.2%, with survivors experiencing prolonged hospital stays. A higher Sequential Organ Failure Assessment (SOFA) score (adjusted hazards ratio [aHR], 1.25; 95% confidence interval [CI] 1.17-1.35) and shock status (aHR, 2.12; 95% CI 1.14-3.94) independently predicted day-28 mortality. Colistin-based therapy reduced day-28 mortality in patients with shock, a SOFA score of ≥ 13, and Acinetobacter baumannii-related BSI. CONCLUSIONS: CRGNB-BSI led to high mortality in critically ill patients with ESRD. Day-28 mortality was independently predicted by a higher SOFA score and shock status. In patients with higher disease severity and Acinetobacter baumannii-related BSI, colistin-based therapy improved treatment outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.
- School of Medicine, China Medical University, Taichung, Taiwan.
- Department of Chest Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
- Institute of Emergency and Critical Care Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Cancer and Immunology Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Zitieren
APA
Lin, Y. C., Yang, K. Y., Peng, C. K., Chan, M. C., Sheu, C. C., Feng, J. Y., Wang, S. H., Huang, W. H., Chen, C. M., Chen, D. H., Chen, C. L., & TCARE (Taiwan Critical Care and Infection) Group (2025). Clinical outcomes of carbapenem-resistant gram-negative bacterial bloodstream infection in patients with end-stage renal disease in intensive care units: a multicenter retrospective observational study. Infection. https://doi.org/10.1007/s15010-024-02343-5
Vancouver
Lin YC, Yang KY, Peng CK, Chan MC, Sheu CC, Feng JY, et al. Clinical outcomes of carbapenem-resistant gram-negative bacterial bloodstream infection in patients with end-stage renal disease in intensive care units: a multicenter retrospective observational study. Infection. 2025. doi:10.1007/s15010-024-02343-5
BibTeX
@article{Lin2025,
author = {Lin, Yu-Chao and Yang, Kuang-Yao and Peng, Chung-Kan and Chan, Ming-Cheng and Sheu, Chau-Chyun and Feng, Jia-Yih and Wang, Sheng-Huei and Huang, Wei-Hsuan and Chen, Chia-Min and Chen, Ding-Han and Chen, Chieh-Lung and TCARE (Taiwan Critical Care and Infection) Group, TCARE (Taiwan Critical Care and Infection) Group},
title = {Clinical outcomes of carbapenem-resistant gram-negative bacterial bloodstream infection in patients with end-stage renal disease in intensive care units: a multicenter retrospective observational study},
journal = {Infection},
year = {2025},
doi = {10.1007/s15010-024-02343-5}
}
EUVIMED